article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

The global ADC market is expected to continue this steep upward trajectory and is anticipated to exceed $16 Billion by 2026. 2 However, when dosed at the MTD, ADCs display improved efficacy over small molecules in oncology trials. 3D rendering of Antibody Drug Conjugate Molecules.